The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle

Journal of Clinical Investigation

Volumn 97, Issue 12, 1996, Pages 2705-2713

  Kelley, David E ^a   Mintun, Mark A ^b   Watkins, Simon C ^a   Simoneau, Jean Aime ^c   Jadali, Fayegh ^b   Fredrickson, Alan ^a   Beattie, Janice ^a   Thériault, Remy ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

glucose transport; Glut 4; insulin resistance; positron emission tomography; skeletal muscle

Indexed keywords

CITRATE SYNTHASE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUCOSE TRANSPORTER; HEXOKINASE; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; INSULIN INFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERCUTANEOUS BIOPSY; PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOLEMMA; THIGH; VASTUS LATERALIS MUSCLE;

EID: 0029948964     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118724     Document Type: Article

References (58)

1. Katz, A., B.L. Nyomba, and C. Bogardus. 1988. No accumulation of glucose in human skeletal muscle during euglycemic hyperinsulinemia. Am. J. Physiol. (Endocrinol. Metab.) 255:E942-E945.
2. Ziel, F.H., N. Venkatesan, and M.B. Davidson. 1988. Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats. Diabetes. 37:885-890.
3. Kahn, B. 1992. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J. Clin. Invest. 89:1367-1374.
4. Pederson, O., J.F. Bak, P.H. Andersen, S. Lund, D.E. Moller, J.S. Flier, and B.B. Kahn. 1990. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 39:865-870.
5. Garvey, W.T., L. Maianu, J.A. Hancock, A.M. Golichowski, and A. Baron. 1992. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes. 41:465-475.
6. Baroni, M.G., R.S. Oelbaum, P. Pozzilli, J. Stocks, S.-R. Li, V. Fiore, and D.J. Galton. 1992. Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Hum Genet. 88:557-561.
7. Choi, W.-H., S. O'Rahilly, J.B. Buse, A. Rees, R. Morgan, J. Flies, and D.E. Moller. 1991. Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects. Diabetes. 40:1712-1718.
8. Bell, G.I., T. Kayano, J.B. Buse, C.F. Burant, J. Takeda, D. Lin, H. Fukumoto, and S. Seino. 1990. Molecular biology of mammalian glucose transporters. Diabetes Care. 13(3):198-208.
9. Klip, A., and M.R. Paquet. 1990. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care. 13:228-243.
10. Laakso, M., M. Malkki, and S.S. Deeb. 1995. Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes. 44:330-334.
11. 142 → His substitution. Diabetes. 44:340-346.
12. Echwald, S.M., C. Bjorbaek, T. Hansen, J.O. Clausen, H. Vestergaard, J.R. Zierath, R. Printz, D.K. Granner, and O. Pederson. 1995. Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity. Diabetes. 44:347-353.
13. Kelley, D.E., and J.-A. Simoneau. 1994. Impaired free fatty acid utilization by skeletal muscle in non-insulin dependent diabetes mellitus. J. Clin. Invest. 94:2349-2356.
14. DeFronzo, R.A., J.D. Tobin, and R. Andres. 1979. Glucose clamp technique: a method of quantifying insulin secretion and resistance. Am. J. Physiol. 237:E214-E223.
15. Butler, P.C., E.J. Kryshak, M. Marsh, and R.A. Rizza. 1990. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM: evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes. 39:1371-1380.
16. 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322:223-228.
17. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89:1069-1075.
18. Bonadonna, R.C., M.P. Saccomani, L. Seely, K.S. Zych, E. Ferrannini, C. Cobelli, and R.A. DeFronzo. 1993. Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes. 42:191-198.
19. Bonadonna, R.C., S. Del Prato, M.P. Saccomani, E. Bonora, G. Gulli, E. Ferrannini, D. Bier, C. Cobelli, and R.A. DeFronzo. 1993. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J. Clin. Invest. 92:486-494.
20. Bonnadonna, R.C., M.P. Saccomani, S. Del Prato, E. Bonora, D. Bier, C. Cobelli, and R.A. DeFronzo. 1994. Mechanisms of normalization of muscle glucose uptake by hyperglycemia in NIDDM. Diabetes 43:72A.
21. Hansen, P.A., E.A. Gulve, and J.O. Holloszy. 1994. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J. Appl. Physiol. 76(2):979-985.
22. 18F]Fluoro-D-GIucose for Metabolic Studies: Current Status. Appl. Radiat. Isot. 37:663-668.
23. Phelps, M.E., S.C. Huang, E.J. Hoffman, C. Selin, L. Sokoloff, and D.E. Uhl. 1979. Tomographic Measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-Fluoro-2-deoxy-D-glucose: Validation of method. Ann. Neurol. 6:371-388.
24. 18F]fluoro-D-glucose transport and phosphorylation rates in myocardium using dual-tracer kinetic experiments. FEBS Lett. 216:128-132.
25. 14-C] deoxyglucose method of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:897-916.
26. Nuutila, P., V.A. Kinisto, J. Knwuti, U. Ruotsalainen, M. Teräs, M. Haaparanta, O. Solin, and H. Yki-Jarvinen. 1992. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J. Clin. Invest. 89:1767-1774.
27. Nuutila, P., M.J. Knuuti, M. Mäki, H. Laine, U. Ruotsalainen, M. Teräa, M. Haaparanta, O. Solin, and H. Yki-Jarvinen. 1995. Gender and insulin sensitivity in the heart and in skeletal muscles. Diabetes. 44:31-36.
28. Nuutila, P., M. Maki, H. Laine, M.J. Knvuti, U. Ruotsalainen, M. Luotolahti, M. Hoaparanta, O. Solin, A. Jula, V.A. Kaivisto, L.M. Voijo-Pulkki, and H. Jki-Jarvinen. 1995. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J. Clin. Invest. 96:1003-1009.
29. Mossberg, K.A., and H. Taegtmeyer. 1992. Time course of skeletal muscle glucose uptake during euglycemic hyperinsulinemia in the anesthetized rabbit: afluorine-18-2-Deoxy-2-fluoro-D-glucose Study. J. Nucl. Med. 33:1523-1529.
30. Selberg, O., W. Burchert, J. v.d.Hoff, G.J. Meyer, H. Hundeshagen, E. Radoch, H.-J. Balks, and M. J. Muller. 1993. Insulin resistance in liver cirrhosis: positron emission tomography scan analysis of skeletal muscle glucose metabolism. J. Clin. Invest. 91:1897-1902.
31. Annane, D., D. Duboc, B. Mazoyer, P. Merlet, M. Fiorelli, B. Eymard, H. Radvanyi, C. Junien, M. Fardeau, P. Gajdos, F. Guerin, and A. Syrota. 1994. Correlation between decreased myocardial glucose phosphorylation and the dna mutation size in myolonic dystrophy. Circulation. 90:2629-2634.
32. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
33. Evans, W., S. Phinney, and V. Young. 1982. Suction applied to a muscle biopsy maximizes sample size. Med. Sci. Sports. Exer. 14:101-102.
34. Finegood, D., R. Bergman, and M. Vranic. 1988. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes. 37:1025-1034.
35. 18F]fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 27:235.
36. Revich, M., A. Alavi, A. Wolf, J. Fowler, J. Russell, C. Aractt, R.R. MacGregor, C.Y. Shiru, H. Atkins, A. Anand, R. Dann, and J.H. Greenberg. 1985. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constant for [18F] Fluorodeoxyglucose and [11C]Deoxyglucose. J. Cereb. Blood Flow Metab. 9:179-192.
37. Piper, R., L.J. Hess, and D.E. James. 1991. Differential sorting of two glucose transporters in insulin-sensitive cells. Am. J. Physiol. 260 (Cell Physiol. 29):C570-C580.
38. Howald, H., D. Pette, J.-A. Simoneau, A. Uber, H. Hoppler, and P. Cerretelli. 1990. III. Effects of chronic hypoxia on muscle enzymes activities. Int. J. Sports Med. 11:S10-S14.
39. Katzen, H.M., D.D. Soderman, and C.E. Wiley. 1970. Multiple forms of hexokinase. Activities associated with subcellular particulate and soluble fractions of normal and streptozotocin diabetic rat tissues. J. Biol. Chem. 245:4081-4096.
40. Colberg, S.R., J.-A. Simoneau, L.F. Thaete, and D.E. Kelley. 1995. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J. Clin. Invest. 95:1846-1853.
41. Pette, D., and R.S. Staron. 1990. Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev. Physiol. Biochem. Pharmacol. 116:1-76.
42. Kelley, D.E., J.P. Reilly, T. Veneman, and L.J. Mandarino. 1990. Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E923-E929.
43. Voipio-Pulkki, L.-M. and P. Nuutilia. 1993. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J. Nucl. Med. 34:2064-2067.
44. Kelley, D.E., and L.J. Mandarino. 1990. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 86:1999-2007.
45. Ohtake, T., I. Yokoyama, T. Wantanabe, T. Monose, J. Serezawa, J. Nishikawa, and Y. Sasaki. 1995. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J. Nucl. Med. 36: 456-463.
46. Garvey, T.W., T.P. Huecksteadt, S. Matthaei, and J.M. Olefsky. 1988. Role of glucose transporters in the cellular insulin resistance of Type II non-insulin-dependent diabetes mellitus. J. Clin. Invest. 81: 1528-1536.
47. Dohm, G.L., E.B. Tapscott, W.J. Portes, D.J. Dobbs, E.G. Flickinger, D. Meelheim, T. Fushiki, S.M. Atkinson, C. Elton, and J.F. Caro. 1988. An in vitro human muscle preparation suitable for metabolic studies decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82:486-494.
48. Sherman, W.M., A.L. Katz, C.L. Cutler, R.T. Withers, and J.L. Ivy. 1988. Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am. J. Physiol. 255 (Endocrinol. Metab. Physiol.):E374-E382.
49. Rodnick, K.J., J.W. Slot, D.R. Studelska, D.E. Hanpeter, L.J. Robinson, H.J. Geuze, and D.E. James. 1992. Immunocytochemical and biochemical studies of GLUT4 in rat skeletal muscle. J. Biol. Chem. 267(9):6278-6285.
50. Guma, A., J.R. Zierath, H. Wallberg-Henriksson, and A. Klip. 1995. Insulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle. Am. J. Physiol. 268 (Endocrinol. Metab. 31):E613-E622.
51. Kong, X., J. Manchester, S. Salmons, and J.C. Lawrence. Jr. 1994. Glucose transporters in single skeletal muscle fibers. J. Biol. Chem. 17:12963-12967.
52. Postic, C., A. Leturque, R.L. Printz, P. Maulard, M. Loiseau, D.K. Grannes, and J. Girard. 1994. Development and regulation of glucose transporter and hexokinase expression in rat. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E548-E559.
53. Hofmann, S., and D. Pette. 1994. Low-frequency stimulation of rat fast-twitch muscle enhances the expression of hexokinase II and both the translocation and expression of glucose transporter 4 (Glut-4). Eur. J. Biochem. 219:307-315.
54. Katz, A., and I. Raz. 1994. Hexokinase kinetics in human skeletal muscle after hyperinsulinemia, hyperglycemia and hyperepinephrinaemia. Acta Physiol. Scand. 151:527-530.
55. Simoneau, J.-A., S.R. Colberg, F.L. Thaete, and D.E. Kelley. 1995. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J. 9:273-278.
56. Hickey, M.S., M.D. Weidner, K.E. Gavigan, D. Zheng, G.L. Tyndall, and J.A. Houmard. 1995. The insulin action-fiber type relationship in humans is muscle group specific. Am. J. Physiol. 269 (Endocrinol. Metab. 32):E150-154.
57. Laakso, M., S.V. Edelman, G. Brechtel, and A.D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J. Clin. Invest. 85:1844-1852.
58. Lillioja, S., A. Young, C. Cutler, J. Ivy, W. Abbot, J. Zawadzki, H. Yki-Jarvinen, L. Christin, T. Secomb, and C. Bogardus. 1987. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J. Clin. Invest. 80:415-424.